News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,219 Results
Type
Article (6661)
Company Profile (58)
Press Release (226495)
Multimedia
Podcasts (8)
Webinars (7)
Section
Business (63959)
Career Advice (346)
Deals (12730)
Drug Delivery (28)
Drug Development (18682)
Employer Resources (28)
FDA (6530)
Job Trends (5206)
News (104256)
Policy (8666)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (680)
Accelerated approval (8)
Adcomms (2)
Allergies (56)
Alliances (21653)
ALS (46)
Alzheimer's disease (511)
Antibody-drug conjugate (ADC) (51)
Approvals (6707)
Artificial intelligence (306)
Autoimmune disease (33)
Automation (31)
Bankruptcy (82)
Best Places to Work (4731)
BIOSECURE Act (3)
Biosimilars (87)
Biotechnology (44)
Bladder cancer (58)
Brain cancer (19)
Breast cancer (171)
Cancer (1183)
Cardiovascular disease (102)
Career advice (307)
Career pathing (10)
CAR-T (43)
CDC (4)
Cell therapy (162)
Cervical cancer (12)
Clinical research (16420)
Collaboration (838)
Compensation (145)
Complete response letters (23)
COVID-19 (868)
CRISPR (36)
C-suite (259)
Cystic fibrosis (32)
Data (1676)
Decentralized trials (2)
Denatured (5)
Depression (52)
Diabetes (159)
Diagnostics (3333)
Digital health (31)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (95)
Drug pricing (37)
Drug shortages (7)
Duchenne muscular dystrophy (24)
Earnings (23462)
Editorial (8)
Employer resources (28)
Events (29953)
Executive appointments (374)
FDA (7859)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (588)
Gene editing (57)
Generative AI (19)
Gene therapy (134)
GLP-1 (334)
Government (993)
Grass and pollen (4)
Guidances (188)
Healthcare (6822)
HIV (33)
Huntington's disease (7)
IgA nephropathy (15)
Immunology and inflammation (40)
Immuno-oncology (10)
Indications (51)
Infectious disease (965)
Inflammatory bowel disease (57)
Inflation Reduction Act (2)
Influenza (45)
Intellectual property (104)
Interviews (57)
IPO (5386)
IRA (8)
Job creations (653)
Job search strategy (239)
JPM (12)
Kidney cancer (2)
Labor market (15)
Layoffs (74)
Leadership (11)
Legal (1427)
Liver cancer (15)
Longevity (5)
Lung cancer (148)
Lymphoma (77)
Machine learning (22)
Management (13)
Manufacturing (406)
MASH (20)
Medical device (7418)
Medtech (7451)
Mergers & acquisitions (7882)
Metabolic disorders (360)
Multiple sclerosis (39)
NASH (2)
Neurodegenerative disease (93)
Neuropsychiatric disorders (13)
Neuroscience (869)
NextGen: Class of 2026 (2608)
Non-profit (1110)
Now hiring (11)
Obesity (179)
Opinion (74)
Ovarian cancer (26)
Pain (114)
Pancreatic cancer (59)
Parkinson's disease (78)
Partnered (18)
Patents (219)
Patient recruitment (146)
Peanut (18)
People (17081)
Pharmaceutical (11)
Pharmacy benefit managers (10)
Phase 1 (4337)
Phase 2 (6859)
Phase 3 (6359)
Pipeline (1881)
Policy (46)
Postmarket research (621)
Preclinical (1701)
Press Release (22)
Prostate cancer (59)
Psychedelics (12)
Radiopharmaceuticals (81)
Rare diseases (229)
Real estate (1998)
Recruiting (8)
Regulatory (7745)
Reports (14)
Research institute (696)
Resumes & cover letters (52)
Rett syndrome (7)
RNA editing (5)
RSV (17)
Schizophrenia (46)
Series A (91)
Series B (75)
Service/supplier (6)
Sickle cell disease (23)
Special edition (4)
Spinal muscular atrophy (28)
Sponsored (24)
Startups (983)
State (2)
Stomach cancer (1)
Supply chain (58)
Tariffs (8)
The Weekly (3)
Vaccines (290)
Venture capital (17)
Weight loss (115)
Women's health (45)
Worklife (4)
Date
Last 7 days (210)
Last 30 days (780)
Last 365 days (10151)
2026 (998)
2025 (10485)
2024 (12687)
2023 (14291)
2022 (20541)
2021 (22294)
2020 (21939)
2019 (18878)
2018 (13797)
2017 (11657)
2016 (10740)
2015 (12225)
2014 (8728)
2013 (7205)
2012 (7712)
2011 (7533)
2010 (6393)
Location
Africa (177)
Alabama (41)
Alaska (2)
Arizona (97)
Arkansas (5)
Asia (12793)
Australia (1766)
California (3222)
Canada (1302)
China (292)
Colorado (238)
Connecticut (179)
Delaware (146)
Europe (32088)
Florida (655)
Georgia (195)
Hawaii (2)
Idaho (44)
Illinois (442)
India (48)
Indiana (331)
Iowa (9)
Japan (147)
Kansas (72)
Kentucky (13)
Louisiana (9)
Maine (29)
Maryland (474)
Massachusetts (2084)
Michigan (178)
Minnesota (377)
Mississippi (5)
Missouri (81)
Montana (22)
Nebraska (12)
Nevada (45)
New Hampshire (50)
New Jersey (1213)
New Mexico (18)
New York (806)
North Carolina (705)
North Dakota (8)
Northern California (1371)
Ohio (159)
Oklahoma (10)
Oregon (19)
Pennsylvania (760)
Puerto Rico (15)
Rhode Island (25)
South America (334)
South Carolina (52)
South Dakota (1)
Southern California (1336)
Tennessee (73)
Texas (567)
United States (13524)
Utah (106)
Vermont (1)
Virginia (103)
Washington D.C. (23)
Washington State (215)
West Virginia (2)
Wisconsin (90)
Wyoming (1)
233,219 Results for "formulated solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome
December 15, 2025
·
9 min read
In partnership with PII
Bridging Formulation and Device: Integrated Supply Chain Strategies for U.S. Pharma Manufacturing
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development with drug delivery device design—and leveraging a single‐vendor ecosystem—can deliver significant time, cost, and regulatory advantages for US‑focused drug products, according to industry experts.
December 8, 2025
·
5 min read
·
Jennifer Smith-Parker
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
February 5, 2026
·
8 min read
Press Releases
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab
November 18, 2025
·
6 min read
Press Releases
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
September 17, 2025
·
4 min read
Press Releases
Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity
January 5, 2026
·
6 min read
Press Releases
Starton Therapeutics Granted New U.S. Patent #12,390,457 Titled “Stable Solutions of Immunomodulatory Imide Compounds for Parenteral Use” a Formulation of STAR-LLD
September 17, 2025
·
4 min read
Press Releases
Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
February 3, 2026
·
5 min read
Press Releases
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief
January 20, 2026
·
7 min read
1 of 23,322
Next
